Northwell Health

Ascertain is a collaborative venture between Northwell Health and Aegis Ventures, aimed at transforming healthcare through innovative company creation. This organization focuses on systematically developing, launching, and commercializing healthcare AI companies, utilizing a comprehensive platform that integrates medical, technological, data, and business resources. By addressing critical issues related to quality, equity, and cost in healthcare, Ascertain seeks to improve patient care and experience. The organization is dedicated to placing patient needs at the forefront of its business models and technology solutions, ultimately striving to enhance long-term health outcomes and advance the overall quality of care.

Avandra Imaging is a health technology company that facilitates the sharing and analysis of medical imaging and clinical data. It aims to accelerate medical research and improve patient care by providing a comprehensive data ecosystem for pharmaceutical companies, medical device manufacturers, and researchers.

Truveta is a health data platform that collaborates with physicians, life science researchers, and others in the healthcare community to compile medical records from partner organizations, connecting treatments with outcomes and various health factors. The platform aggregates data across multiple healthcare systems to identify and harmonize medical information, enabling researchers and clinicians to analyze treatment effectiveness and support informed decision making across patient care.

Prolucent Health offers technology-driven solutions for modern workforce management in healthcare. Its platform employs artificial intelligence and advanced analytics to optimize labor needs, streamline recruitment processes, enhance workforce utilization, and reduce costs.

Clarapath specializes in automating laboratory processes for pathology. Its flagship product, Section Star, streamlines microtomy using a tape transfer method. The company offers routine histology services, digital pathology solutions, and quantitative image analysis. Serving academic researchers, clinical labs, and physicians, Clarapath aims to enhance lab medicine quality, safety standards, and throughput while reducing costs.

Hume AI, established in 2021, specializes in developing AI models that enable technology to understand and respond to human emotions. Headquartered in New York and San Jose, the company offers a range of products, including expression measurement models, text-to-speech models, and speech-language models, all grounded in advanced research from psychology and machine learning. Hume AI's technology analyzes facial expressions, voice inflections, text, and other data sources to gain insights into human feelings and engagement. By prioritizing scientific rigor and ethical AI practices, Hume AI serves diverse industries, enhancing human-technology interactions with empathy and authenticity.

Optain develops medical equipment and software that leverage artificial intelligence and retinal imaging to enable noninvasive, real-time diagnosis of eye and systemic health conditions. By using the eye as a gateway to detect early signs of disease, the company supports physicians in accurate assessment and early intervention while emphasizing affordable, scalable clinical assistance solutions that improve healthcare accessibility and screening capabilities.

Memora Health is a San Francisco-based healthcare technology company that develops an intelligent care enablement platform to automate outpatient communication and digital workflows. The platform helps clinicians focus on top-of-license practice by digitizing and triaging patient-reported concerns and data, enabling proactive two-way communication and support for patients along complex care journeys, and it partners with health systems, health plans, and digital health companies to transform care delivery for care teams and patients.

Neuvotion is a medical device company developing neurostimulation technologies for rehabilitation and physical therapy. The company combines targeted neurostimulation with artificial intelligence to restore movement and independence for individuals with movement impairment resulting from stroke or injury. Its platform supports both patient-directed therapy and clinician oversight, enabling patients to guide their own treatment while clinicians monitor progress in person or remotely.

Hume AI, established in 2021, specializes in developing AI models that enable technology to understand and respond to human emotions. Headquartered in New York and San Jose, the company offers a range of products, including expression measurement models, text-to-speech models, and speech-language models, all grounded in advanced research from psychology and machine learning. Hume AI's technology analyzes facial expressions, voice inflections, text, and other data sources to gain insights into human feelings and engagement. By prioritizing scientific rigor and ethical AI practices, Hume AI serves diverse industries, enhancing human-technology interactions with empathy and authenticity.

Holmusk is a health data analytics company focused on real-world evidence in behavioral health and chronic diseases. It combines specialty behavioral health data with its analytics platform to generate evidence-based insights that support treatment decisions and the development of new therapies. The company offers predictive algorithms and a proprietary modeling platform to analyze real-world data, enabling personalized medicine and data-driven decision making for healthcare providers, researchers, and life sciences organizations.

Lazzaro Medical develops minimally invasive medical devices to treat tracheobronchomalacia (TBM), a condition affecting millions worldwide. Their platform includes a robotic tracheal scaffold system for airway support, diagnostic tools for rapid disease identification, surgical training programs, and patented endotracheal tubes, enabling healthcare providers to deliver safer, more efficient treatments with reduced operating and recovery times.

Playback Health designs and develops digital platforms for patient engagement in healthcare. Its core product enables practitioners to create and share personalized multimedia content with patients, enhancing communication about diagnoses, treatments, and post-care instructions. The company's secure, AI-driven SaaS platform integrates with existing systems, automating processes and improving patient outcomes. Currently deployed in 30 hospitals across the U.S.

Violet is a platform that helps the healthcare industry deliver more inclusive services. It enables identity-centered care for everyone.

Health Note is an AI-powered health data management platform that collects patient information through voice and digital intake tools, automatically formats it into clinical notes, and integrates with electronic medical records to streamline documentation and pre-visit workflows. The platform is frictionless and platform-agnostic, enabling patients to participate in their care without apps or portals and reducing administrative burden for clinicians while improving care team efficiency. Founded in 2018 and based in San Francisco, Health Note aims to simplify clinical documentation and EMR integration.

Brightline, Inc. is a pediatric behavioral health care provider that focuses on supporting children and their families through innovative technology and integrated care. Established in 2019 and headquartered in Palo Alto, California, Brightline offers a range of services including behavioral therapy, psychiatry, medication support, speech-language therapy, and occupational therapy. The company emphasizes virtual behavioral health services and a collaborative care team to address the diverse needs of children at various developmental stages. Originally named Emilio Health, Inc., the company rebranded to Brightline in May 2020, reflecting its commitment to delivering accessible and comprehensive behavioral health solutions.

Ascertain is a collaborative venture between Northwell Health and Aegis Ventures, aimed at transforming healthcare through innovative company creation. This organization focuses on systematically developing, launching, and commercializing healthcare AI companies, utilizing a comprehensive platform that integrates medical, technological, data, and business resources. By addressing critical issues related to quality, equity, and cost in healthcare, Ascertain seeks to improve patient care and experience. The organization is dedicated to placing patient needs at the forefront of its business models and technology solutions, ultimately striving to enhance long-term health outcomes and advance the overall quality of care.

Transcarent is a consumer-directed health and care platform serving employees of self-insured employers and their families. It combines software, technology, health guides, and data science to provide unbiased information, trusted guidance, and access to high-value care. The company connects users with an integrated ecosystem of high-value providers and health services, enabling customers to exercise choice and transparency for addressing a broad range of healthcare challenges.

Nova Leah specializes in medical device cybersecurity. Its flagship product, SelectEvidence, is an intelligent risk management solution that helps manufacturers identify vulnerabilities and comply with security standards.

Holmusk is a health data analytics company focused on real-world evidence in behavioral health and chronic diseases. It combines specialty behavioral health data with its analytics platform to generate evidence-based insights that support treatment decisions and the development of new therapies. The company offers predictive algorithms and a proprietary modeling platform to analyze real-world data, enabling personalized medicine and data-driven decision making for healthcare providers, researchers, and life sciences organizations.

Clarapath specializes in automating laboratory processes for pathology. Its flagship product, Section Star, streamlines microtomy using a tape transfer method. The company offers routine histology services, digital pathology solutions, and quantitative image analysis. Serving academic researchers, clinical labs, and physicians, Clarapath aims to enhance lab medicine quality, safety standards, and throughput while reducing costs.

Founded in 2014, Cognixion develops neurotech platforms that enhance communication for individuals with disabilities. Its flagship product is an assisted reality headset featuring Brain-Computer Interface technology, enabling users to translate brain signals into words and actions, facilitating effortless expression and environmental control.

Truveta is a health data platform that collaborates with physicians, life science researchers, and others in the healthcare community to compile medical records from partner organizations, connecting treatments with outcomes and various health factors. The platform aggregates data across multiple healthcare systems to identify and harmonize medical information, enabling researchers and clinicians to analyze treatment effectiveness and support informed decision making across patient care.

Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Peerbridge Health is a digital health company based in New York that develops wireless and wearable ECG monitoring solutions for remote cardiac care. Its primary offering, Peerbridge Cor, is a multi-channel remote ECG patch that captures continuous heart data for up to seven days to support arrhythmia detection, along with CorHRV and Cor+ variants that monitor heart rate rhythm, respiratory rate, temperature, oxygen saturation, and heart rate variability. The company emphasizes medical-grade monitoring through mobile health technology designed for seamless user experience and real-time data delivery to physicians. Peerbridge Health holds patents related to monitoring vital signs with wearable technology, reflecting its focus on continuous, accurate vital-sign assessment for medical, wellness, and performance applications. Founded in 2012 and based in New York, the company aims to improve diagnoses and patient outcomes through accessible remote monitoring.

Gauss Surgical, Inc. is a medical technology company that specializes in real-time blood monitoring solutions to enhance patient outcomes in surgical and obstetric settings. Founded in 2011 and headquartered in Los Altos, California, Gauss Surgical develops the Triton system, which includes various models suited for different medical needs. Triton assists healthcare professionals in monitoring and estimating blood loss during procedures, allowing for timely intervention in cases of hemorrhage. The system offers objective metrics for blood loss, thereby facilitating better clinical decision-making regarding transfusions. Serving the healthcare sector primarily in the United States, Gauss Surgical's products are designed to integrate seamlessly into existing medical practices, using sophisticated algorithms and HIPAA-compliant technology to deliver accurate monitoring in real time.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

Vestagen Technical Textiles is a company based in Orlando, Florida, that specializes in the development, manufacturing, and marketing of advanced textile products and technologies. Founded in 2009, Vestagen holds exclusive North American rights to patented Swiss technologies for medical textiles, which can be adapted for various applications, including medical uniforms and athletic apparel. The company focuses on addressing the critical need for continuous-wear solutions in the healthcare industry. Its flagship product, VESTEX Active Barrier, is designed to protect healthcare workers and patients by significantly reducing the risks associated with fluid exposure during routine use of general-purpose attire. This innovative fabric helps to minimize the acquisition and retention of harmful microorganisms on clothing, enhancing safety in healthcare settings.

Salaso is a developer of a software as a service platform that enables physiotherapists and other healthcare professionals to prescribe and deliver high-quality exercise videos to patients via smartphones, tablets, or personal computers. The platform includes an e-learning tool designed to engage patients with the content and promote adherence to prescribed home exercise programs. By facilitating the delivery of physiotherapy exercises, Salaso aims to support the recovery process for patients recovering from injuries, ensuring that healthcare providers can effectively manage and monitor their patients' rehabilitation efforts.

Conversa Health, Inc. is a company that specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare providers. Founded in 2013 and headquartered in Portland, Oregon, with additional offices in New York, Research Triangle Park, and San Francisco, Conversa offers a Virtual Care and Communication Platform designed to improve efficiency, patient engagement, and clinical outcomes. Its Digital Checkup platform automates personalized messaging based on comprehensive patient profiles developed from electronic health records, biometric devices, and self-reported data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health tech firms, facilitating proactive communication and management of patients in various contexts, such as chronic care, oncology, and wellness. Conversa’s automated care platform effectively engages patients, triaging them to appropriate care settings when necessary, and has been adopted by notable organizations for its COVID-19 Virtual Care Programs, which include symptom checking, patient check-ins, and lab result delivery.

Peerbridge Health is a digital health company based in New York that develops wireless and wearable ECG monitoring solutions for remote cardiac care. Its primary offering, Peerbridge Cor, is a multi-channel remote ECG patch that captures continuous heart data for up to seven days to support arrhythmia detection, along with CorHRV and Cor+ variants that monitor heart rate rhythm, respiratory rate, temperature, oxygen saturation, and heart rate variability. The company emphasizes medical-grade monitoring through mobile health technology designed for seamless user experience and real-time data delivery to physicians. Peerbridge Health holds patents related to monitoring vital signs with wearable technology, reflecting its focus on continuous, accurate vital-sign assessment for medical, wellness, and performance applications. Founded in 2012 and based in New York, the company aims to improve diagnoses and patient outcomes through accessible remote monitoring.

HealthReveal is a company that offers a cloud-based platform for clinical analytics. This platform uses advanced analytics and biomonitoring technology to continually monitor and analyze patient physiology and care by integrating real-time data streams from various sources like clinical, operational, and biometric data. The primary goal of HealthReveal's platform is to ensure adherence to evidence-based care guidelines, enabling early detection and treatment of chronic diseases, which can help patients recover faster and reduce healthcare costs.

Clarapath specializes in automating laboratory processes for pathology. Its flagship product, Section Star, streamlines microtomy using a tape transfer method. The company offers routine histology services, digital pathology solutions, and quantitative image analysis. Serving academic researchers, clinical labs, and physicians, Clarapath aims to enhance lab medicine quality, safety standards, and throughput while reducing costs.

PurpleSun is an early stage healthcare technology company based out of New York City. They are focused on providing smart, light-based technology solutions to the healthcare industry for infection prevention, diagnostics and treatment. Their company’s novel light technology platform will be utilized throughout the continuum of care, within hospitals, long term care and surgical centers. The smart devices will set the stage for patient safety through the highest of quality in medical equipment disinfection. Their goal is to prevent healthcare acquired infections, which will ultimately save lives, reduce costs and enhance safety for patients and caregivers. Their clinical data proves best in class efficacy and performance of our platform, and positions PurpleSun to illuminate the healthcare arena.

Avizia is a provider of telehealth and remote conferencing solutions designed to facilitate comprehensive telehealth programs within healthcare systems. The company focuses on enhancing collaborative care by connecting medical professionals across distances through its innovative telemedicine platform. Avizia’s end-to-end solution encompasses telemedicine devices, workflow management software, and integration with electronic health records, alongside a variety of peripherals such as digital stethoscopes and examination cameras. This platform allows healthcare providers to conduct remote medical consultations and training sessions, simulating an in-person experience. By leveraging advanced video technology, Avizia enables real-time, high-definition video collaboration among patients and healthcare professionals, thereby streamlining care coordination and expanding access to medical expertise.